IWC
WHWK

Integrated Wealth Concepts’s Whitehawk Therapeutics WHWK Stock Holding History

Integrated Wealth Concepts’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$604 Buy
+132
New +$549 ﹤0.01% 5625

Other funds holding WHWK

YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Integrated Wealth Concepts's WHWK Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in Whitehawk Therapeutics (WHWK) in Q2 2026: 132 shares worth $604. The stake represents ﹤0.01% of the portfolio and ranks #5625 among its holdings.

78 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

  • Integrated Wealth Concepts held 132 shares of Whitehawk Therapeutics worth $604 as of Q2 2026.
  • Whitehawk Therapeutics was a new Integrated Wealth Concepts position in Q2 2026.
  • Whitehawk Therapeutics made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #5625 holding.
  • 78 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.